Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says prostate cancer is the second-most common cause of cancer death in men, accounting for 14 per cent of all male cases.

Prostate cancer overtook breast cancer as the most commonly diagnosed cancer in England earlier this year. NHS data examined by Prostate Cancer UK revealed that 50,751 men were diagnosed with prostate cancer in 2022,

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men.

Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – which means we can potentially target them for quicker and more effective treatment of a condition that affects 1.

There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because the results can be unreliable. A high PSA does not always mean cancer. It can go up if there is an infection, for example.